Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 15/20 | 0.43 |
| ▸ | CA1 | P00915 | 14/20 | 0.41 |
| ▸ | MMP1 | P03956 | 5/20 | 0.41 |
| ▸ | MMP2 | P08253 | 5/20 | 0.41 |
| ▸ | MMP9 | P14780 | 5/20 | 0.41 |
| ▸ | MMP8 | P22894 | 5/20 | 0.41 |
| ▸ | MMP13 | P45452 | 5/20 | 0.41 |
| ▸ | F2 | P00734 | 4/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5960751 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960743 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960736 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960765 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960798 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3144765 | 0.98 | CA2 (0.40) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960742 | 0.91 | CA2 (0.32) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960769 | 0.82 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960770 | 0.82 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5960775 | 0.82 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303451-B1 | SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2019-08-21 | — | — | EP | claimed |
| US-9901912-B2 | Super acids and bases as dehydrocondensation catalysts | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-02-27 | — | — | US | claimed |
| US-20160354769-A1 | SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-12-08 | — | — | US | claimed |
| EP-0143323-B1 | PROCESS FOR AN ANTHRACYCLINE DERIVATIVE, AND AN ANTHRACYCLINONE DERIVATIVE USEFUL FOR THE PROCESS | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1988-10-26 | — | — | EP | claimed |
| US-4564674-A | Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1986-01-14 | — | — | US | claimed |
| EP-0143323-A2 | Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1985-06-05 | — | — | EP | claimed |
| EP-3303451-B1 | SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2019-08-21 | — | — | EP | disclosed |
| US-9901912-B2 | Super acids and bases as dehydrocondensation catalysts | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-02-27 | — | — | US | disclosed |
| US-20160354769-A1 | SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-12-08 | — | — | US | disclosed |
| EP-1688423-A1 | Silylation of hydroxyl group-containing compounds | Shin-Etsu Chemical Co., Ltd. (JP) | 2006-08-09 | — | — | EP | disclosed |
| EP-1334975-B1 | Silylation of hydroxyl group-containing compounds | SHINETSU CHEMICAL CO (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-6875880-B2 | Silylation of hydroxyl groups | SHIN-ETSU CHEMICAL, CO., LTD. (JP) | 2005-04-05 | — | — | US | disclosed |
| EP-1334975-A1 | Silylation of hydroxyl group-containing compounds | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-08-13 | — | — | EP | disclosed |
| US-20030139619-A1 | Silylation of hydroxyl groups | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-07-24 | — | — | US | disclosed |
| EP-0143323-B1 | PROCESS FOR AN ANTHRACYCLINE DERIVATIVE, AND AN ANTHRACYCLINONE DERIVATIVE USEFUL FOR THE PROCESS | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1988-10-26 | — | — | EP | disclosed |
| US-4564674-A | Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1986-01-14 | — | — | US | disclosed |
| EP-0143323-A2 | Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1985-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354769-A1 | SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS | STS, DHPS, FDFT1 | CA2 195/4885CA1 6/4885MMP1 2419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.